Health Product Regulatory Authority issues EUGMP certificate to Concord Biotech’s Valthera facility

06 Jun 2024 Evaluate

Health Product Regulatory Authority of Ireland has issued EUGMP certificate to Concord Biotech’s unit II (Valthera facility) located at Dholka in Ahmedabad, Gujarat. 

In May 2024, Saudi Food and Drug Authority had successfully completed inspection of Concord Biotech’s manufacturing unit II, (formulation facility), located at Valthera from May 14, 2024 to May 16, 2024.

Concord Biotech is an India-based biopharma company and one of the leading global developers and manufacturers of select fermentation-based APIs across Immunosuppressants and oncology.

Concord Biotech Share Price

1339.80 -7.35 (-0.55%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×